These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

835 related items for PubMed ID: 33839230

  • 21. Effect of lipid composition on RNA-Lipid nanoparticle properties and their sensitivity to thin-film freezing and drying.
    AboulFotouh K, Southard B, Dao HM, Xu H, Moon C, Williams Iii RO, Cui Z.
    Int J Pharm; 2024 Jan 25; 650():123688. PubMed ID: 38070660
    [Abstract] [Full Text] [Related]

  • 22. Development of a high-throughput platform for screening lipid nanoparticles for mRNA delivery.
    Cui L, Pereira S, Sonzini S, van Pelt S, Romanelli SM, Liang L, Ulkoski D, Krishnamurthy VR, Brannigan E, Brankin C, Desai AS.
    Nanoscale; 2022 Jan 27; 14(4):1480-1491. PubMed ID: 35024714
    [Abstract] [Full Text] [Related]

  • 23. Design and lyophilization of mRNA-encapsulating lipid nanoparticles.
    Wang T, Yu T, Li W, Liu Q, Sung TC, Higuchi A.
    Int J Pharm; 2024 Sep 05; 662():124514. PubMed ID: 39067550
    [Abstract] [Full Text] [Related]

  • 24. Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles.
    Elia U, Ramishetti S, Rosenfeld R, Dammes N, Bar-Haim E, Naidu GS, Makdasi E, Yahalom-Ronen Y, Tamir H, Paran N, Cohen O, Peer D.
    ACS Nano; 2021 Jun 22; 15(6):9627-9637. PubMed ID: 33480671
    [Abstract] [Full Text] [Related]

  • 25. Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery.
    Maeki M, Uno S, Niwa A, Okada Y, Tokeshi M.
    J Control Release; 2022 Apr 22; 344():80-96. PubMed ID: 35183654
    [Abstract] [Full Text] [Related]

  • 26. Low energy nebulization preserves integrity of SARS-CoV-2 mRNA vaccines for respiratory delivery.
    van Rijn CJM, Vlaming KE, Bem RA, Dekker RJ, Poortinga A, Breit T, van Leeuwen S, Ensink WA, van Wijnbergen K, van Hamme JL, Bonn D, Geijtenbeek TBH.
    Sci Rep; 2023 May 31; 13(1):8851. PubMed ID: 37258559
    [Abstract] [Full Text] [Related]

  • 27. Novel Ionizable Lipid Nanoparticles for SARS-CoV-2 Omicron mRNA Delivery.
    Long J, Yu C, Zhang H, Cao Y, Sang Y, Lu H, Zhang Z, Wang X, Wang H, Song G, Yang J, Wang S.
    Adv Healthc Mater; 2023 May 31; 12(13):e2202590. PubMed ID: 36716702
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Rational design and combinatorial chemistry of ionizable lipids for RNA delivery.
    Xu Y, Golubovic A, Xu S, Pan A, Li B.
    J Mater Chem B; 2023 Jul 19; 11(28):6527-6539. PubMed ID: 37345430
    [Abstract] [Full Text] [Related]

  • 30. A Basic Method for Formulating mRNA-Lipid Nanoparticle Vaccines in the Lab.
    Jarzebska NT, Frei J, Mellett M, Kündig TM, Pascolo S, Reichmuth AM.
    Methods Mol Biol; 2024 Jul 19; 2786():237-254. PubMed ID: 38814398
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Bile acid-containing lipid nanoparticles enhance extrahepatic mRNA delivery.
    Patel SK, Billingsley MM, Mukalel AJ, Thatte AS, Hamilton AG, Gong N, El-Mayta R, Safford HC, Merolle M, Mitchell MJ.
    Theranostics; 2024 Jul 19; 14(1):1-16. PubMed ID: 38164140
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine.
    Muramatsu H, Lam K, Bajusz C, Laczkó D, Karikó K, Schreiner P, Martin A, Lutwyche P, Heyes J, Pardi N.
    Mol Ther; 2022 May 04; 30(5):1941-1951. PubMed ID: 35131437
    [Abstract] [Full Text] [Related]

  • 35. Ionizable Amino Lipids Distribution and Effects on DSPC/Cholesterol Membranes: Implications for Lipid Nanoparticle Structure.
    Dehghani-Ghahnaviyeh S, Smith M, Xia Y, Dousis A, Grossfield A, Sur S.
    J Phys Chem B; 2023 Aug 10; 127(31):6928-6939. PubMed ID: 37498794
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion.
    Qin Z, Bouteau A, Herbst C, Igyártó BZ.
    PLoS Pathog; 2022 Sep 10; 18(9):e1010830. PubMed ID: 36054264
    [Abstract] [Full Text] [Related]

  • 39. Induction of Bleb Structures in Lipid Nanoparticle Formulations of mRNA Leads to Improved Transfection Potency.
    Cheng MHY, Leung J, Zhang Y, Strong C, Basha G, Momeni A, Chen Y, Jan E, Abdolahzadeh A, Wang X, Kulkarni JA, Witzigmann D, Cullis PR.
    Adv Mater; 2023 Aug 10; 35(31):e2303370. PubMed ID: 37172950
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.